To get the best possible experience using our website, we recommend that you upgrade to latest version of this browser or install another web browser. See our Browser Support/Compatibility page for supported browsers list.
Contact
Scientists are reporting the development and successful initial testing of a new form of methotrexate — the mainstay anticancer drug — designed to be given as nose drops rather than injected. It shows promise as a more effective treatment for brain cancer, they say. The report appears in ACS’ Molecular Pharmaceutics, a bi-monthly journal…
The antibacterial ingredient in some soaps, toothpastes, odor-fighting socks, and even computer keyboards is pointing scientists toward a long-sought new treatment for a parasitic disease that affects almost two billion people. Their report on how triclosan became the guiding light for future development of drugs for toxoplasmosis appears in ACS’ monthly Journal of Medicinal Chemistry…
An unusual substance known as “dry water,” which resembles powdered sugar, could provide a new way to absorb and store carbon dioxide, the major greenhouse gas that contributes to global warming, scientists reported here today at the 240th National Meeting of the American Chemical Society. The powder shows bright promise for a number of other uses, they said. It may…
Imagine devices that capture electricity from the air — much like solar cells capture sunlight — and using them to light a house or recharge an electric car. Imagine using similar panels on the rooftops of buildings to prevent lightning before it forms. Strange as it may sound, scientists already are in the early stages of developing such devices, according to a report presented here…
Portable devices that use a laser beam to probe bones, teeth, and other parts of the body for early signs of diseases like osteoporosis and tooth decay may seem like something out of science fiction. But those devices are moving closer to reality, according to an article in the current issue of Chemical & Engineering News (C&EN), ACS’ weekly newsmagazine…
This is the latest American Chemical Society (ACS) Office of Public Affairs Weekly PressPac with news from ACS’ 38 peer-reviewed journals and Chemical & Engineering News.
This information is intended for your personal use in news gathering and reporting and should not be distributed to others. Anyone using advance ACS Office of Public Affairs Weekly PressPac information for stocks or securities dealing may be guilty of insider trading under the federal Securities Exchange Act of 1934.
Please cite the individual journal, or the American Chemical Society, as the source of this information.
The American Chemical Society is a non-profit organization chartered by the U.S. Congress. With more than 161,000 members, ACS is the world’s largest scientific society and a global leader in providing access to chemistry-related research through its multiple databases, peer-reviewed journals and scientific conferences. Its main offices are in Washington, D.C., and Columbus, Ohio.
